Q/C Technologies, Inc. (QCLS) stock
QCLSNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
$0.33+0.01 (+4.05%)
Close on Nov 17, 2026Market cap $2.74MP/E –Yield –
Q/C Technologies price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Q/C Technologies's price to sales ratio was 472.4× on Jun 30, 2020, against 187.8× a year earlier. Over the last 5 years it ranged from 26.2× to 492.4×, with a median of 255.8×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2020 | Jun 30, 2020 | 472.4× | +410.5 |
| 2019 | Dec 31, 2019 | 62.0× | −199.8 |
| 2018 | Dec 31, 2018 | 261.8× | +235.6 |
| 2017 | Dec 29, 2017 | 26.2× | −219.8 |
| 2016 | Dec 30, 2016 | 246.0× | +113.0 |
| 2015 | Dec 31, 2015 | 132.9× | −234.6 |
| 2014 | Dec 31, 2014 | 367.5× | – |
See a number that looks wrong?